Greenbrook TMS (Greenbrook TMS) Insider Ownership : 1.84 % (As of Jun. 06, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Greenbrook TMS's insider ownership is 1.84%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Greenbrook TMS's Institutional Ownership is 3.63%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Greenbrook TMS's Float Percentage Of Total Shares Outstanding is 40.03%.

Greenbrook TMS Insider Ownership Historical Data

The historical data trend for Greenbrook TMS's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS Insider Ownership Chart

Greenbrook TMS Historical Data

The historical data trend for Greenbrook TMS can be seen below:

	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Insider Ownership	1.96	1.96	1.84	1.84	1.84	1.84

Greenbrook TMS Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Greenbrook TMS (Greenbrook TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4

Website

https://www.greenbrooktms.com

Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.